Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Newgenivf Group Ltd. (NIVF:NASDAQ), powered by AI.
Newgenivf Group Ltd. is currently trading at $1.02. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Newgenivf Group Ltd. on Alpha Lenz.
Newgenivf Group Ltd.'s P/E ratio is 0.0.
“Newgenivf Group Ltd. trades at a P/E of 0.0 (undervalued) with strong ROE of 77.2%.”
Ask for details →Newgenivf Group Ltd. is a leading company in the healthcare sector, specializing in advanced fertility treatments and reproductive health services. As a provider of in vitro fertilization (IVF) solutions, Newgenivf plays a crucial role in offering hope and effective treatment options for individuals and couples facing fertility challenges. The company's primary purpose is to enhance reproductive possibilities through cutting-edge technologies and experienced medical professionals. Newgenivf Group Ltd. operates a network of fertility clinics equipped with state-of-the-art laboratories and a team dedicated to research and clinical excellence. The company's services extend beyond IVF to include a wide range of reproductive health care options such as genetic testing, egg and sperm donation programs, and fertility preservation techniques. Its impact is significant in the healthcare industry, touching the lives of patients globally and contributing to the growing assisted reproductive technology market. In a financial context, Newgenivf Group Ltd. is considered a key player in its field, reflecting growth trends in health services and biotechnology. As a publicly traded entity, it offers investors exposure to the burgeoning demand for fertility treatments driven by societal trends and advancements in medical diagnostics and care.
“Newgenivf Group Ltd. trades at a P/E of 0.0 (undervalued) with strong ROE of 77.2%.”
Ask for details →Newgenivf Group Ltd. (ticker: NIVF) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 76 employees. Market cap is $4,294.
The current price is $1.02 with a P/E ratio of 0x and P/B of 0x.
ROE is 77.23% and operating margin is -226.95%. Annual revenue is $5M.